Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27773 | 181 | 33.3 | 74% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1581 | 6646 | COCAINE//NEONATAL ABSTINENCE SYNDROME//PRENATAL COCAINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | RETROVIROL EPIGENET | Address | 2 | 43% | 2% | 3 |
| 2 | POLYANTIGENIC IMMUNOMODULATOR | Author keyword | 1 | 100% | 1% | 2 |
| 3 | V HA RAS ONCOGENE | Author keyword | 1 | 100% | 1% | 2 |
| 4 | ONCOMOUSE | Author keyword | 1 | 33% | 1% | 2 |
| 5 | BIPOLAR DISORDERS PROGRAM NEUROSCICIBERSAM | Address | 1 | 50% | 1% | 1 |
| 6 | CAMCODA | Address | 1 | 50% | 1% | 1 |
| 7 | CHICAGO MACS | Address | 1 | 50% | 1% | 1 |
| 8 | FAMILY COMMUNITY MED 1501 N CAMPBELL AVE | Address | 1 | 50% | 1% | 1 |
| 9 | DNA IMAGE ANALYSIS | Author keyword | 0 | 20% | 1% | 2 |
| 10 | ANTIDOPAMINERGIC | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | POLYANTIGENIC IMMUNOMODULATOR | 1 | 100% | 1% | 2 | Search POLYANTIGENIC+IMMUNOMODULATOR | Search POLYANTIGENIC+IMMUNOMODULATOR |
| 2 | V HA RAS ONCOGENE | 1 | 100% | 1% | 2 | Search V+HA+RAS+ONCOGENE | Search V+HA+RAS+ONCOGENE |
| 3 | ONCOMOUSE | 1 | 33% | 1% | 2 | Search ONCOMOUSE | Search ONCOMOUSE |
| 4 | DNA IMAGE ANALYSIS | 0 | 20% | 1% | 2 | Search DNA+IMAGE+ANALYSIS | Search DNA+IMAGE+ANALYSIS |
| 5 | ANTIDOPAMINERGIC | 0 | 33% | 1% | 1 | Search ANTIDOPAMINERGIC | Search ANTIDOPAMINERGIC |
| 6 | COCAINE ADMINISTRATION | 0 | 33% | 1% | 1 | Search COCAINE+ADMINISTRATION | Search COCAINE+ADMINISTRATION |
| 7 | HIV 1 SEROPOSITIVE | 0 | 33% | 1% | 1 | Search HIV+1+SEROPOSITIVE | Search HIV+1+SEROPOSITIVE |
| 8 | HIV EXPRESSION | 0 | 33% | 1% | 1 | Search HIV+EXPRESSION | Search HIV+EXPRESSION |
| 9 | LP BM5 MURINE LEUKEMIA | 0 | 25% | 1% | 1 | Search LP+BM5+MURINE+LEUKEMIA | Search LP+BM5+MURINE+LEUKEMIA |
| 10 | MEAN OPTICAL DENSITY | 0 | 25% | 1% | 1 | Search MEAN+OPTICAL+DENSITY | Search MEAN+OPTICAL+DENSITY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | COCAINE FREEBASE | 6 | 100% | 2% | 4 |
| 2 | THYMIC CELL SUBSETS | 6 | 100% | 2% | 4 |
| 3 | DICHLOROISOPROTERENOL | 2 | 50% | 2% | 3 |
| 4 | PROTEIN MALNOURISHED MICE | 2 | 50% | 2% | 3 |
| 5 | MURINE RETROVIRUS INFECTION | 2 | 31% | 3% | 5 |
| 6 | MONONUCLEAR CELL COCULTURES | 1 | 19% | 4% | 7 |
| 7 | ACETYLCHOLINE CONCENTRATION | 0 | 33% | 1% | 1 |
| 8 | DRUG CUE | 0 | 33% | 1% | 1 |
| 9 | IMMUNE CELL FUNCTION | 0 | 18% | 1% | 2 |
| 10 | LP BM5 | 0 | 14% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Associations between use of crack cocaine and HIV-1 disease progression: Research findings and implications for mother-to-infant transmission | 2011 | 8 | 59 | 12% |
| IMMUNOMODULATION BY COCAINE - A NEUROENDOCRINE MEDIATED RESPONSE | 1990 | 58 | 48 | 19% |
| AIDS, DRUGS OF ABUSE AND THE IMMUNE-SYSTEM - A COMPLEX IMMUNOTOXICOLOGICAL NETWORK | 1991 | 52 | 61 | 10% |
| INVITRO IMMUNOTOXICOLOGY AND IMMUNOPHARMACOLOGY - STUDIES ON DRUGS OF ABUSE | 1990 | 9 | 53 | 6% |
| Okadaic acid-like toxin in systemic lupus erythematosus patients: Hypothesis for toxin-induced pathology, immune dysregulation, and transactivation of herpesviruses | 1996 | 1 | 77 | 3% |
| The yin and yang of cancer therapeutics | 2005 | 0 | 52 | 2% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RETROVIROL EPIGENET | 2 | 43% | 1.7% | 3 |
| 2 | BIPOLAR DISORDERS PROGRAM NEUROSCICIBERSAM | 1 | 50% | 0.6% | 1 |
| 3 | CAMCODA | 1 | 50% | 0.6% | 1 |
| 4 | CHICAGO MACS | 1 | 50% | 0.6% | 1 |
| 5 | FAMILY COMMUNITY MED 1501 N CAMPBELL AVE | 1 | 50% | 0.6% | 1 |
| 6 | POST PROGRAM MED PSYCHIAT | 0 | 25% | 0.6% | 1 |
| 7 | MED VIRGINIA PHARMACOL TOXICOL | 0 | 12% | 1.1% | 2 |
| 8 | BEHAV COMMUNITY HLTH SERV | 0 | 13% | 0.6% | 1 |
| 9 | OGBURN STOUFFER SOCIAL ORG | 0 | 13% | 0.6% | 1 |
| 10 | COMPREHENS DRMICROGRAM | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000234136 | COCAETHYLENE//COCAINE METABOLISM//COCAINE METABOLITES |
| 2 | 0.0000208844 | MAIDS//LP BM5//LP BM5 MURINE LEUKEMIA VIRUS |
| 3 | 0.0000199885 | METHIONINE ENKEPHALIN//ENDOCRINE NEUROSCI NEUROIMMUNOMODULAT S//SECT MED SCI |
| 4 | 0.0000113843 | CRACK LUNG//COCAINE INDUCED SEIZURES//COCAINE TOXICITY |
| 5 | 0.0000110599 | PSYCHONEUROPHARMACOL//NORADRENALINE DOPAMINE INTERACTIONS//NOREPINEPHRINE DOPAMINE INTERACTIONS |
| 6 | 0.0000077058 | PRIMATE INFECT DIS//SYNTHETIC COPOLYMER ANTIGENS//EMORY ALCOHOL LUNG BIOL |
| 7 | 0.0000055255 | SOCIAL DEFEAT//SOCIAL STRESS//CONDITIONED DEFEAT |
| 8 | 0.0000051695 | CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE |
| 9 | 0.0000050455 | VILLADIA//CRASSULACEAE//SEMPERVIVUM TECTORUM |
| 10 | 0.0000048627 | SOLUBLE INTERLEUKIN 2 RECEPTOR//SOLUBLE INTERLEUKIN 2 RECEPTOR SIL 2R//SOLUBLE INTERLEUKIN 2 RECEPTOR SIL2R |